BBOX1 and hepatocellular carcinoma: In addition, apoptosis analysis showed that BBOX1-AS1 overexpression reduced the sorafenib-induced apoptosis of HCC cells, while BBOX1-AS1 silencing had the opposite effect (Figure 3F).